Access Microdosing Policy 
Cannabis Law Report
AUGUST 7, 2022
There is a rapidly growing movement to create safe access to psychedelic medicines. As the psychedelic renaissance grows, consumer interest in microdosing psychedelics for wellness is building. Unfortunately, none of these initiatives have created policy specific to the adult use of microdosing psychedelics.
Veriheal
MAY 12, 2023
Secret Service Revises Cannabis Employment Policy In order to keep up with the growing movement for cannabis legalization, several federal organizations have revised their cannabis policies. Last month, the USSS announced an update to its employment policy. Previously , the USSS took an age-based approach to its cannabis policy.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Veriheal
MARCH 20, 2023
Using psilocybin in small doses, or microdosing, has been shown to aid in the treatment of various mental health issues, including anxiety, depression, PTSD, and obsessive-compulsive disorder. Psilocybin Policies Around the Nation Let’s explore where psilocybin is legal, decriminalized, and on the ballot across U.S.
Veriheal
OCTOBER 20, 2021
Veriheal does not support illegally consuming alternative therapeutic substances but acknowledges that it transpires because of the current illicit status, which we strive to change by advocating for research, legal access, and responsible consumption. Always consult a physician before attempting psychedelic therapy. Talk about mixed signals.
Cannabis Law Report
JANUARY 7, 2022
.) – Plant Medicine Coalition, a nonprofit membership and advocacy organization that lobbies the federal government regarding psychedelic policy, has changed its name to Psychedelic Medicine Coalition (PMC). Patrick Moher , CEO of Microdose. PMC is delighted to publicize its first annual National Psychedelic Policy Roundtable.
Cannabis Law Report
FEBRUARY 10, 2022
The report includes: A deep dive into psychedelic drug policy reform efforts and successes in 2021, with a focus on key jurisdictions including the U.S. A look at key research and clinical trials that were published in 2021, with analysis of themes like microdosing and SSRI interactions. Access the PDF here. and Canada.
Cannabis Law Report
FEBRUARY 2, 2022
In addition to his support of advocacy for regenerative organic agriculture, David directs Dr. Bronner’s resources to support animal advocacy, wage equality, and drug policy reform. Patrick Moher is an industrious entrepreneur working in Psychedelics and Cannabis, currently the President at Microdose Psychedelic Insights.
Expert insights. Personalized for you.
52 
Let's personalize your content